31118868|t|Sialorrhea in patients with ALS: current treatment options.
31118868|a|Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder of the motor neuron, which selectively affects it both at central (first motor-neuron) and peripheral level (second motor-neuron). The disease shows up at a mean age of 56 years and the most affected are males. Although ALS may start as a bulbar or spinal disease, with the progression of the disease typically both become evident. Pharmacological approved treatments for ALS are still limited and include riluzole and edaravone which improve survival over time. Despite this, ALS leads to progressive muscle involvement and requires a complex multidisciplinary approach to manage increasing disability which goes beyond motor neurons. Sialorrhea is, amongst others, one of the most disabling symptoms in ALS. The complexity in managing saliva is due to a muscular spasticity and to a scarce palatino-lingual muscles control, rather than to an overproduction of saliva. These features could increase the risk of aspiration pneumonia and limit the use of noninvasive mechanical ventilation. We reviewed the treatment for sialorrhea in ALS patients that are available at this time, emphasizing pros and cons for each approach. Our purpose is to create a practical tool for the diagnosis, in order to facilitate the quantification and management of sialorrhea in everyday practice.
31118868	0	10	Sialorrhea	Disease	MESH:D012798
31118868	14	22	patients	Species	9606
31118868	28	31	ALS	Disease	MESH:D000690
31118868	60	89	Amyotrophic lateral sclerosis	Disease	MESH:D000690
31118868	91	94	ALS	Disease	MESH:D000690
31118868	113	139	neurodegenerative disorder	Disease	MESH:D019636
31118868	360	363	ALS	Disease	MESH:D000690
31118868	379	403	bulbar or spinal disease	Disease	MESH:D055534
31118868	512	515	ALS	Disease	MESH:D000690
31118868	546	554	riluzole	Chemical	MESH:D019782
31118868	559	568	edaravone	Chemical	MESH:D000077553
31118868	617	620	ALS	Disease	MESH:D000690
31118868	642	660	muscle involvement	Disease	MESH:C566343
31118868	776	786	Sialorrhea	Disease	MESH:D012798
31118868	845	848	ALS	Disease	MESH:D000690
31118868	905	915	spasticity	Disease	MESH:D009128
31118868	1052	1072	aspiration pneumonia	Disease	MESH:D011015
31118868	1160	1170	sialorrhea	Disease	MESH:D012798
31118868	1174	1177	ALS	Disease	MESH:D000690
31118868	1178	1186	patients	Species	9606
31118868	1386	1396	sialorrhea	Disease	MESH:D012798
31118868	Negative_Correlation	MESH:D019782	MESH:D000690
31118868	Negative_Correlation	MESH:D000077553	MESH:D000690

